The Neurobiology of Bipolar Disorder

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 123 C, Issue 1, 2003, Pages 76-84

  Berns, Gregory S ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Magnetic resonance imaging; Schizophrenia

Indexed keywords

BIPOLAR DISORDER; BRAIN FUNCTION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM FUNCTION; DISEASE ASSOCIATION; HUMAN; NEUROBIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY;

EID: 0242291141     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.20016     Document Type: Review

References (65)

1. Abe M, Herzog ED, Block GD. 2000. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 11:3261-3264.
2. Ahearn EP, Steffens DC, Cassidy F, Van Meter SA, Provenzale JM, Seldin MF, Weisler RH, Krishnan KR. 1998. Familial leukoencephalopathy in bipolar disorder. Am J Psychiatry 155:1605-1607.
3. Ahearn EP, Speer MC, Chen YT, Steffens DC, Cassidy F, Van Meter S, Provensale JM, Weisler RH, Krishnan KR. 2002. Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype. Am J Med Genet 114:652-658.
4. Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. 1995. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 152:1139-1144.
5. Angst J. 1998. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50:143-151.
6. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, Peyser CE, Pearlson GD. 1994. Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. Am J Psychiatry 151:687-693.
7. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM. 1985. Cerebral metabolic rates for glucose in mood disorders studied with positron emission tomography (PET) and (F-18)-fluoro2-deoxyglucose (FDG). Arch Gen Psychiatry 42:441-447.
8. Berns GS, Martin M, Proper SM. 2002. Limbic hyperreactivity in bipolar II disorder. Am J Psychiatry 159:304-306.
9. Bos JL, de Rooij J, Reedquist KA. 2001. Rap1 signalling: adhering to new models. Nat Rev Mol Cell Biol 2:369-377.
10. 18F]2-deoxyglucose in affective illness. J Affect Disord 10:137-152.
11. Bunney WE, Bunney BG. 2000. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22:335-345.
12. Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. 1998. Anterior cingulate cortex, error detection and the online monitoring of performance. Science 280:747-749.
13. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. 2000. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75:1729-1734.
14. Cummings JL. 1993. The neuroanatomy of depression. J Clin Psychiatry 54:14-20.
15. Cummings JL, Mendez MF. 1984. Secondary mania with focal cerebrovascular lesions. Am J Psychiatry 141:1084-1087.
16. Dewan MJ, Haldipur CV, Lane EE, Ispahani A, Boucher MF, Major LF. 1988. Bipolar affective disorder. I. Comprehensive quantitative computed tomography. Acta Psychiatr Scand 77:670-676.
17. Drevets WC, Price JL, Videen TO, Todd RD, Raichle ME. 1995. Metabolic abnormalities in the subgenual prefrontal cortex and ventral striatum in mood disorders. Soc Neurosci Abs 21:260.
18. Duman RS, Nestler EJ. 1995. Signal transduction pathways for catecholamine receptors. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press. p 303-320.
19. Duman RS, Nakagawa S, Mahlberg J. 2001. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25:836-844.
20. Dupont RM, Jernigan TL, Heindel W, Butters N, Shafer K, Wilson T, Hesselink J, Gillin JC. 1995. Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 52:747-755.
21. Friedman E, Hoau YW, Levinson D, Connell TA, Singh H. 1993. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 33:520-525.
22. Goodwin FK, Jamison KR. 1990. Manic-depressive illness. New York: Oxford University Press.
23. Jauhar P, Weller MP. 1982. Psychiatric morbidity and time zone changes: a study of patients from Heathrow airport. Br J Psychiatry 140:231-235.
24. Jope RS, Jenden DJ, Ehrlich BE, Diamond JM. 1978. Choline accumulates in erythrocytes during lithium therapy. N Engl J Med 299:833-834.
25. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Esleman S, Wittchen HU, Kendler KS. 1994. Lifetime and 12-month prevalence of DSM-II-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
26. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R, Cheng HM, Brady TJ, Rosen BR. 1992. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 89:5675-5679.
27. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. 2001. Neurophysiological investigation of the basis of the fMRI signal. Nature 412:150-157.
28. Lyoo IK, Lee HK, Jung JH, Noam GG, Renshaw PF. 2002. White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders. Comp Psychiatry 43:361-368.
29. Manji HK, Lenox RH. 2000. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48:518-530.
30. Manji HK, Duman RS. 2001. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 35:5-49.
31. Manji HK, Potter WZ, Lenox RH. 1995. Signal transduction pathways: molecular targets for lithium's actions. Arch Gen Psychiatry 52:531-543.
32. McDonald WM, Tupler LA, Marsteller FA, Figiel GS, DiSouza S, Nemeroff CB, Krishnan KR. 1999. Hyperintense lesions on magnetic resonance images in bipolar disorder. Biol Psychiatry 45:965-971.
33. Meador-Woodruff JH, Hogg AJ, Smith RE. 2001. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 55:631-640.
34. Mitterauer B. 2000. Clock genes, feedback loops and their possible role in the etiology of bipolar disorders: an integrative model. Med Hypotheses 55:155-159.
35. Montague PR, Berns GS. 2002. Neural economics and the biological substrates of valuation. Neuron 36:265-284.
36. Nonaka S, Hough CJ, Chuan DM. 1998. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 95:2642-2647.
37. Norris SD, Krishnan KR, Ahearn E. 1997. Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 21:1323-1337.
38. Ogawa S, Lee TM, Kay AR, Tank DW. 1990. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87:9868-9872.
39. Pariante CM, Miller AH. 2001. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404.
40. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R. 2000. Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder. J Psychiatr Res 34:99-104.
41. Pillai JJ, Friedman L, Stuve TA, Trinidad S, Jesberger JA, Lewin JS, Findling RL, Swales TP, Schulz SC. 2002. Increased presence of white matter hyperintensities in adolescent patients with bipolar disorder. Psychiatry Res 114:51-56.
42. Reppert SM, Weaver DR. 2002. Coordination of circadian timing in mammals. Nature 418:935-941.
43. Risby ED, Hsiao JK, Manji HK, Bitran J, Moses F, Zhou DF, Potter WZ. 1991. The mechanisms of action of lithium. Arch Gen Psychiatry 48:513-524.
44. Rybakowski JK, Twardowska K. 1999. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33:363-370.
45. Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522.
46. Schlegel S, Krtezschmar K. 1987. Computed tomography in affective disorders. Part I. Ventricular and sulcal measurements. Biol Psychiatry 22:4-14.
47. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ. 1995. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38:797-802.
48. Shapiro MF, Lehman AF, Greefield S. 1983. Biases in the laboratory diagnosis of depression in medical practice. Arch Intern Med 143:2085-2088.
49. Starkstein SE, Fedoroff P, Berthier ML, Robinson RG. 1991. Manic-depressive and pure manic states after brain lesions. Biol Psychiatry 29:149-158.
50. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. 2001. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 55:625-629.
51. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. 2000. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry 48:505-517.
52. Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. 1993. Structural brain abnormalities in first-episode mania. Biol Psychiatry 33:602-609.
53. Strakowski SM, Adler CA, DelBello MP. 2002a. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? Bipolar Disord 4:80-88.
54. Strakowski SM, DelBello MP, Adler C, Cecil KM, Sax KW. 2002b. Neuroimaging in bipolar disorder. Bipolar Disord 2:148-164.
55. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E. 1992. Hypothalamic-pituitary-adreno-cortical function in mixed and pure mania. Acta Psychiatr Scand 85:270-274.
56. Swayze VW, Andreasen NC, Alliger RJ, Ehrhardt JC, Yuh WT. 1990. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 47:1054-1059.
57. Swayze VW, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. 1992. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 31:221-240.
58. Wang X, Nemeroff CB. 2003. Biological distinction between unipolar and bipolar disorders. In: Soares JC, Gershon S, editors. Handbook of medical psychiatry. New York: Marcel Dekker.
59. Watson S, Young AH. 2002. Hypothalamic-pituitary-adrenal axis function in bipolar disorder. Clin Approaches Bipolar Disord 1:57-64.
60. Wehr TA. 1989. Sleep loss: a preventable cause of mania and other excited states. J Clin Psychiatry 50:45-47.
61. Yildiz A, Sachs GS, Dorer DJ, Renshaw PF. 2001. 31P nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis. Psychiatry Res 106:181-191.
62. Young DM. 1995. Psychiatric morbidity in travelers to Honolulu, Hawaii. Comp Psychiatry 36:224-228.
63. Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ. 1991. Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar disorder. Brain Res 553:323-326.
64. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykewiwicz O, Warsh JJ. 1993. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 61:890-898.
65. Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykewiwicz O. 1994. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder. Biol Psychiatry 35:121-127.